Neoplasms: all 9,610 studies
Page 88 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer CenterTerminatedNCT00670605
- Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular CarcinomaTerminatedNCT00669136Phase 1
- Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid MalignanciesCompletedNCT00669097Phase 1
- Combination Chemotherapy in Treating Older Patients With Solid Tumour,CompletedNCT00664911Phase 4
- A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid TumorsTerminatedNCT00664586Phase 1
- A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced CancerCompletedNCT00664170Phase 1
- Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid TumorsCompletedNCT00661414Phase 1
- Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological MalignanciesCompletedNCT00660920Phase 1
- Study of GemOx and Vandetanib in Advanced Solid MalignancyCompletedNCT00660725Phase 1
- Study Of Advanced Gastrointestinal Malignancies And Other Solid TumorsCompletedNCT00660426Phase 1
- Neo-adjuvant Therapy and the Effect on Synchronous Metastatic GrowthStatus unknownNCT00659022Phase 2
- Evaluation of KX2-391 in Patients With Advanced MalignanciesCompletedNCT00658970Phase 1
- A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced CancerCompletedNCT00658671Phase 1
- Clinical and Pathologic Studies in Neuroendocrine TumorsWithdrawnNCT00657332
- An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid TumorsStatus unknownNCT00657176Phase 1
- Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed TherapyTerminatedNCT00657098
- Phase 1 Study of MKC-1 in Patients With Advanced CancerCompletedNCT00656461Phase 1
- Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsCompletedNCT00655655Phase 1
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
- A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced MalignanciesTerminatedNCT00652158Phase 1
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantTerminatedNCT00651716
- A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain MetastasesCompletedNCT00649207Phase 1
- Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And LymphomasCompletedNCT00647764Phase 1
- Study of the Efficacy of Kalinox® 170 Bar in Adult OncologyCompletedNCT00646945Phase 4
- Trial of Preoperative Hepatic and Regional Arterial Chemotherapy (PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal CancerStatus unknownNCT00643877Phase 3
- Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic MalignanciesCompletedNCT00642031Phase 1
- Safety Study of Oral Vinorelbine in Subjects With Non-Hematologic MalignanciesStatus unknownNCT00641160Phase 1
- Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid TumorsCompletedNCT00640796Phase 1
- Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00639639Phase 1
- Breath Test for Early Detection of Lung CancerCompletedNCT00639067
- Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorCompletedNCT00638898Phase 1
- A Study of ARRY-334543 in Patients With Advanced CancerCompletedNCT00637702Phase 1
- Study of AZD8931 in Patients With Advanced Solid MalignanciesCompletedNCT00637039Phase 1
- Genasense as a 2-hour Intravenous Infusion in Subjects With Solid TumorsCompletedNCT00636545Phase 1
- ABI-009 Trial in Patients With Advanced Non-hematologic MalignanciesCompletedNCT00635284Phase 1
- Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing ColposcopyCompletedNCT00632190Not applicable
- Oral NRX 194204 in Patients With Refractory MalignanciesTerminatedNCT00630760Phase 1
- Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced MalignanciesCompletedNCT00629473Phase 1
- Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced MalignanciesCompletedNCT00629200Phase 1
- A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid TumorsCompletedNCT00628732Phase 2
- Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused LymphopeniaCompletedNCT00626483Phase 1
- Interactive Voice Response System in Advanced Cancer PatientsCompletedNCT00625638Not applicable
- Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid TumorsWithdrawnNCT00624962Not applicable
- Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology OperationsWithdrawnNCT00624312Phase 2
- A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.CompletedNCT00623870Phase 1
- Aflibercept in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNCT00622414Phase 1
- Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid TumorsCompletedNCT00618735Phase 1
- Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma PatientsCompletedNCT00617253Phase 2
- PR104 and G-CSF in Treating Patients With Solid TumorsCompletedNCT00616213Phase 1
- A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid TumorsCompletedNCT00615446Phase 1
- Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid TumorsCompletedNCT00613145Phase 1
- A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid TumorsCompletedNCT00612209Phase 1
- PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced MalignanciesCompletedNCT00611793Phase 1
- Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid TumorsCompletedNCT00611689Phase 1
- Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia in Patients With An Abnormal Pap SmearWithdrawnNCT00610662
- Bevacizumab and Temsirolimus in Patients With Advanced MalignancyCompletedNCT00610493Phase 1
- Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer PatientsCompletedNCT00610194Phase 1
- Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia RecurrenceSuspendedNCT00609310Phase 2
- IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid TumorCompletedNCT00609141Phase 1
- Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complementary and Alternative MedicineCompletedNCT00608933Phase 3
- Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid TumorsStatus unknownNCT00607984Not applicable
- Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable CancerWithdrawnNCT00607802Not applicable
- Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid TumorsTerminatedNCT00607399Phase 1
- Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid TumorsTerminatedNCT00606879Phase 1
- Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00606814Phase 1
- Pharmacokinetics Study of Liposomal Paclitaxel in HumansCompletedNCT00606515Phase 4
- Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid TumorsCompletedNCT00605618Phase 1/2
- S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenTerminatedNCT00602745Phase 3
- Digital Colposcopy in Finding Cervical Intraepithelial NeoplasiaCompletedNCT00602368Not applicable
- Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsCompletedNCT00602082Phase 2
- A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)CompletedNCT00600496Phase 1
- Molecular Markers in Treatment in Endometrial CancerStatus unknownNCT00598845
- Quality of Life in Patients Undergoing Total Pelvic ExenterationCompletedNCT00597805
- A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)CompletedNCT00596258Phase 2
- Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological MalignanciesCompletedNCT00595686Phase 1
- Risk Factors for Adult-Onset Brain TumorsTerminatedNCT00592865
- Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and LymphomasCompletedNCT00592163Phase 1
- Thoracic OncoGeriatric Assessment (TOGA) TrialsCompletedNCT00591981
- MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid TumorsSuspendedNCT00591682Phase 1
- Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)CompletedNCT00591643Phase 1
- Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's LymphomasCompletedNCT00591422Phase 1
- A Phase I Trial of ZIO-101 in Solid TumorsCompletedNCT00591396Phase 1
- Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid TumorsCompletedNCT00591383Phase 1
- Phase I Study in Advanced Solid TumorsCompletedNCT00591292Phase 1
- Phase I Study of Indibulin in Patients With Solid TumorsCompletedNCT00591136Phase 1
- Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATACompletedNCT00588289
- Estrogen, Diet, Genetics and Endometrial CancerActive, not recruitingNCT00587886
- Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)CompletedNCT00586560Phase 1
- The Study of Barrett's Esophagus: What Are the Factors of ProgressionTerminatedNCT00586404
- CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLLActive, not recruitingNCT00586391Phase 1
- Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot StudyWithdrawnNCT00585819Not applicable
- Prevalence of Lower Urinary Tract Symptoms in Women With Gynecologic Malignancy Planning to Undergo Surgical ManagementWithdrawnNCT00580697
- Trial of Family Focused Grief Therapy in Palliative Care and BereavementCompletedNCT00580515Not applicable
- Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine TumorsCompletedNCT00580463
- Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological MalignanciesStatus unknownNCT00580450Phase 1/2
- Lung Cancer Informational Study (LCIS)CompletedNCT00579215Not applicable
- Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT00576654Phase 1
- Far Infrared Radiation Treatment for Prostate CancerStatus unknownNCT00573820Phase 1
- Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid TumorsCompletedNCT00573690Phase 1
- Open Label, Dose Escalation Phase I Study of AZD2281CompletedNCT00572364Phase 1